| RS2150371841 |
RUNX2
|
Health Risk |
Likely pathogenic |
— |
| RS2150371856 |
RUNX2
|
Health Risk |
Pathogenic |
— |
| RS2150371895 |
RUNX2
|
Health Risk |
Likely pathogenic |
— |
| RS2150371897 |
RUNX2
|
Health Risk |
Pathogenic |
— |
| RS2150371905 |
RUNX2
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS2150371921 |
RUNX2
|
Health Risk |
Likely pathogenic |
— |
| RS2150375968 |
EYS
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 25, Retinitis pigmentosa 25 |
| RS2150387447 |
DEF6
|
Health Risk |
Pathogenic |
Immunodeficiency 87 and autoimmunity, Immunodeficiency 87 and autoimmunity |
| RS2150388709 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS2150388801 |
DEF6
|
Health Risk |
Pathogenic |
Immunodeficiency 87 and autoimmunity, Immunodeficiency 87 and autoimmunity |
| RS2150388869 |
ADGRV1
|
Health Risk |
Pathogenic |
Idiopathic generalized epilepsy, Idiopathic generalized epilepsy |
| RS2150391522 |
KCNQ5
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2150391860 |
KCNQ5
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 46 |
| RS2150398853 |
TCOF1
|
Health Risk |
Likely pathogenic |
Treacher Collins syndrome 1, Treacher Collins syndrome 1 |
| RS2150398890 |
TCOF1
|
Health Risk |
Pathogenic |
Treacher Collins syndrome 1, Treacher Collins syndrome 1 |
| RS2150399547 |
TCOF1
|
Health Risk |
Pathogenic |
Treacher Collins syndrome 1, Treacher Collins syndrome 1 |
| RS2150399759 |
CPLANE1
|
Health Risk |
Pathogenic |
— |
| RS2150400998 |
DNAH8
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2150407470 |
CPLANE1
|
Health Risk |
Pathogenic |
— |
| RS2150407530 |
RUNX2
|
Health Risk |
Likely pathogenic |
— |
| RS2150407600 |
RUNX2
|
Health Risk |
Pathogenic |
Cleidocranial dysostosis, Cleidocranial dysostosis |
| RS2150410774 |
PKHD1
|
Health Risk |
Likely pathogenic |
Autosomal recessive polycystic kidney disease, Polycystic kidney disease 4 |
| RS2150413999 |
PKHD1
|
Health Risk |
Likely pathogenic |
Autosomal dominant polycystic liver disease, Autosomal dominant polycystic liver disease |
| RS2150414452 |
PKHD1
|
Health Risk |
Pathogenic |
Autosomal recessive polycystic kidney disease, Autosomal recessive polycystic kidney disease |
| RS2150415240 |
PKHD1
|
Health Risk |
Pathogenic |
Autosomal recessive polycystic kidney disease, Autosomal recessive polycystic kidney disease |
| RS2150416702 |
PKHD1
|
Health Risk |
Pathogenic |
Autosomal recessive polycystic kidney disease, Autosomal recessive polycystic kidney disease |
| RS2150417202 |
PKHD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive polycystic kidney disease, Polycystic kidney disease 4 |
| RS2150417724 |
PKHD1
|
Health Risk |
Pathogenic |
Enlarged kidney, Hyperechogenic kidneys |
| RS2150418842 |
PKHD1
|
Health Risk |
Likely pathogenic |
Autosomal recessive polycystic kidney disease, Autosomal recessive polycystic kidney disease |
| RS2150418852 |
PKHD1
|
Health Risk |
Likely pathogenic |
Autosomal recessive polycystic kidney disease, Autosomal recessive polycystic kidney disease |
| RS2150421181 |
RUNX2
|
Health Risk |
Likely pathogenic |
Cleidocranial dysostosis, Cleidocranial dysostosis |
| RS2150421206 |
RUNX2
|
Health Risk |
Pathogenic |
— |
| RS2150421218 |
RUNX2
|
Health Risk |
Pathogenic |
Cleidocranial dysostosis, Cleidocranial dysostosis |
| RS2150424894 |
EYS
|
Health Risk |
Pathogenic |
— |
| RS2150424909 |
EYS
|
Health Risk |
Pathogenic |
— |
| RS2150428777 |
LAMB1
|
Health Risk |
Likely pathogenic |
Cobblestone lissencephaly without muscular or ocular involvement, Cobblestone lissencephaly without muscular or ocular involvement |
| RS2150429989 |
LAMB1
|
Health Risk |
Pathogenic |
Cobblestone lissencephaly without muscular or ocular involvement, Cobblestone lissencephaly without muscular or ocular involvement |
| RS2150435584 |
CPLANE1
|
Health Risk |
Likely pathogenic |
Joubert syndrome, Joubert syndrome |
| RS2150448548 |
CPLANE1
|
Health Risk |
Pathogenic |
— |
| RS2150452051 |
RUNX2
|
Health Risk |
Pathogenic |
— |
| RS2150452063 |
RUNX2
|
Health Risk |
Pathogenic |
Cleidocranial dysostosis, Cleidocranial dysostosis |
| RS2150453692 |
RUNX2
|
Health Risk |
Likely pathogenic |
— |
| RS2150453696 |
RUNX2
|
Health Risk |
Likely pathogenic |
— |
| RS2150453876 |
RUNX2
|
Health Risk |
Pathogenic |
— |
| RS2150454165 |
RUNX2
|
Health Risk |
Pathogenic |
— |
| RS2150457602 |
KCNQ5
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2150463984 |
EYS
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinitis pigmentosa 25 |
| RS2150463985 |
EYS
|
Health Risk |
Likely pathogenic |
— |
| RS2150466350 |
EYS
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 25, Retinitis pigmentosa 25 |
| RS2150466512 |
EYS
|
Health Risk |
Pathogenic |
— |
| RS2150474860 |
COL4A4
|
Health Risk |
Likely pathogenic |
Benign familial hematuria, Hematuria |
| RS2150475193 |
COL4A4
|
Health Risk |
Pathogenic |
— |
| RS2150475372 |
COL4A4
|
Health Risk |
Conflicting classifications of pathogenicity |
Hematuria, benign familial |
| RS2150476732 |
COL4A4
|
Health Risk |
Pathogenic |
— |
| RS2150476860 |
COL4A4
|
Health Risk |
Likely pathogenic |
— |
| RS2150476941 |
COL4A4
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS2150477599 |
COL4A4
|
Health Risk |
Likely pathogenic |
Benign familial hematuria, Benign familial hematuria |
| RS2150505385 |
COL4A4
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive Alport syndrome, Benign familial hematuria |
| RS2150505661 |
COL4A4
|
Health Risk |
Pathogenic |
— |
| RS2150506036 |
COL4A4
|
Health Risk |
Likely pathogenic |
Benign familial hematuria, Benign familial hematuria |
| RS2150511876 |
AASS
|
Health Risk |
Pathogenic |
Hyperlysinemia, Hyperlysinemia |
| RS2150512605 |
FGFR1
|
Health Risk |
Pathogenic |
Hypogonadotropic hypogonadism 2 with or without anosmia, Hypogonadotropic hypogonadism 2 with or without anosmia |
| RS2150515547 |
CDK13
|
Health Risk |
Likely pathogenic |
Congenital heart defects, dysmorphic facial features |
| RS2150517037 |
CDK13
|
Health Risk |
Likely pathogenic |
Congenital heart defects, dysmorphic facial features |
| RS2150517060 |
CDK13
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital heart defects, dysmorphic facial features |
| RS2150517916 |
CPLANE1
|
Health Risk |
Pathogenic |
— |
| RS2150520528 |
DNAH8
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2150521592 |
FGFR1
|
Health Risk |
Likely pathogenic |
Hypogonadotropic hypogonadism 2 with or without anosmia, FGFR1-related disorder |
| RS2150521749 |
FGFR1
|
Health Risk |
Likely pathogenic |
Hypogonadotropic hypogonadism 2 with or without anosmia, Hypogonadotropic hypogonadism 2 with or without anosmia |
| RS2150522213 |
COL11A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hearing impairment, Hearing impairment |
| RS2150522747 |
COL11A2
|
Health Risk |
Likely pathogenic |
— |
| RS2150523233 |
COL4A4
|
Health Risk |
Pathogenic |
— |
| RS2150524268 |
FGFR1
|
Health Risk |
Pathogenic |
— |
| RS2150524851 |
COL11A2
|
Health Risk |
Pathogenic |
— |
| RS2150526766 |
CDK13
|
Health Risk |
Likely pathogenic |
Congenital heart defects, dysmorphic facial features |
| RS2150526768 |
CDK13
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital heart defects, dysmorphic facial features |
| RS2150526779 |
CDK13
|
Health Risk |
Likely pathogenic |
— |
| RS2150527930 |
KCNQ5
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, autosomal dominant 46 |
| RS2150532832 |
COL11A2
|
Health Risk |
Likely pathogenic |
Autosomal dominant nonsyndromic hearing loss 13, Autosomal dominant nonsyndromic hearing loss 13 |
| RS2150533516 |
FGFR1
|
Health Risk |
Pathogenic |
Hypogonadotropic hypogonadism 2 with or without anosmia, Hypogonadotropic hypogonadism 2 with or without anosmia |
| RS2150534777 |
COL11A2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2150536000 |
CDK13
|
Health Risk |
Likely pathogenic |
Congenital heart defects, dysmorphic facial features |
| RS2150536009 |
DNAH8
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2150537283 |
FGFR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypogonadotropic hypogonadism 2 with or without anosmia, Hypogonadotropic hypogonadism 2 with or without anosmia |
| RS2150537863 |
FGFR1
|
Health Risk |
Likely pathogenic |
Pfeiffer syndrome, Hypogonadotropic hypogonadism 2 with or without anosmia |
| RS2150544713 |
COL11A2
|
Health Risk |
Likely pathogenic |
— |
| RS2150546942 |
COL11A2
|
Health Risk |
Likely pathogenic |
— |
| RS2150548107 |
ANK1
|
Health Risk |
Pathogenic |
Hereditary spherocytosis type 1, Hereditary spherocytosis type 1 |
| RS2150548120 |
COL11A2
|
Health Risk |
Likely pathogenic |
Otospondylomegaepiphyseal dysplasia, autosomal recessive |
| RS2150548391 |
FGFR1
|
Health Risk |
Pathogenic |
Pfeiffer syndrome, Hypogonadotropic hypogonadism 2 with or without anosmia |
| RS2150548621 |
VARS2
|
Health Risk |
Likely pathogenic |
Combined oxidative phosphorylation defect type 20, Combined oxidative phosphorylation defect type 20 |
| RS2150548677 |
FGFR1
|
Health Risk |
Likely pathogenic |
Hartsfield-Bixler-Demyer syndrome, Hartsfield-Bixler-Demyer syndrome |
| RS2150550526 |
FGFR1
|
Health Risk |
Likely pathogenic |
Hypogonadotropic hypogonadism 2 with or without anosmia, Hypogonadotropic hypogonadism 2 with or without anosmia |
| RS2150551158 |
COL11A2
|
Health Risk |
Pathogenic |
Fibrochondrogenesis 2, Fibrochondrogenesis 2 |
| RS2150552237 |
FGFR1
|
Health Risk |
Pathogenic |
Hypogonadotropic hypogonadism 2 with or without anosmia, Hypogonadotropic hypogonadism 2 with or without anosmia |
| RS2150554560 |
TCOF1
|
Health Risk |
Pathogenic |
— |
| RS2150555528 |
COL11A2
|
Health Risk |
Pathogenic/Likely pathogenic |
Otospondylomegaepiphyseal dysplasia, autosomal dominant |
| RS2150555861 |
TCOF1
|
Health Risk |
Pathogenic |
Treacher Collins syndrome 1, Treacher Collins syndrome 1 |
| RS2150556374 |
ANK1
|
Health Risk |
Likely pathogenic |
— |
| RS2150556792 |
ANK1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spherocytosis type 1, Hereditary spherocytosis type 1 |